Lv3
314 积分 2024-04-28 加入
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
2个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
4个月前
已完结
A safety and efficacy study of allogeneic haematopoietic stem cell transplantation for refractory and relapsed T‐cell acute lymphoblastic leukaemia/lymphoblastic lymphoma patients who achieved complete remission after autologous CD7 chimeric antigen receptor T‐cell therapy
4个月前
已完结
Immune reconstitution after CD7 CAR ‐T cell therapy for refractory/relapsed acute T‐lymphoblastic leukaemia/lymphoblastic lymphoma (R/R T‐ ALL / LBL )
4个月前
已完结
Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial
4个月前
已完结
Expert Consensus on Cytomegalovirus Management in Recipients of CAR-T Cell and Bispecific Antibody Therapies
5个月前
已完结
Systemic capillary leak syndrome
7个月前
已完结
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
7个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
7个月前
已完结
The mechanisms and countermeasures for CAR-T cell expansion and persistence deficiency
7个月前
已完结
皖公网安备34019202002308
